Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 9Observational 3

Sponsor

Cancer Type

Other 3

Conditions

Opioid-Induced Constipation 3Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 165Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × naloxegol × Clear all
NCT03720613 2025-02-12

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

BioDelivery Sciences International

Recruiting
34,532 enrolled
Other

Opioid-Induced Constipation

NCT03638440 2024-06-17

NACASY

Kyowa Kirin Co., Ltd.

Completed
183 enrolled
Other

Opioid-Induced Constipation

NCT04294550 2022-02-28

Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

Fondazione ANT Italia ONLUS

Completed
250 enrolled
Other

Opioid-Induced Constipation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡